![Rainer Lichtenberger](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rainer Lichtenberger
Nessuna posizione attualmente
Storia della carriera di Rainer Lichtenberger
Precedenti posizioni note di Rainer Lichtenberger
Società | Posizione | Inizio | Fine |
---|---|---|---|
Merckle GmbH
![]() Merckle GmbH Pharmaceuticals: MajorHealth Technology Merckle GmbH engages in the manufacture of pharmaceutical products. It offers specialty and generic medicines, as well as over-the-counter drugs. The firm also provides management services for the group. The company was founded in 1881 and is headquartered in Blaubeuren, Germany. | Corporate Officer/Principal | 01/01/2002 | - |
Ratiopharm GmbH
![]() Ratiopharm GmbH Pharmaceuticals: MajorHealth Technology ratiopharm GmbH engages in the production and distribution of generic drugs and pharmaceutical products. It offers pain relievers, nasal sprays, bronchial drops, as well as medicines for treating high blood pressure, cancer, pulmonary arterial hypertension, human immunodeficiency virus infection and acquired immune deficiency syndrome. The company was founded in 1973 and is headquartered in Ulm, Germany. | Corporate Officer/Principal | 01/01/2002 | - |
MERCK KGAA | Direttore Tecnico/Scientifico/R&S | 31/12/2001 | 01/01/2002 |
Corporate Officer/Principal | 01/01/1988 | - | |
Vendite & Marketing | 01/01/1988 | 01/01/2002 | |
Atriva Therapeutics GmbH
![]() Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Amministratore Delegato | 01/04/2015 | - |
Fondatore | 01/04/2015 | - | |
SCT-Spinal Cord Therapeutics GmbH
![]() SCT-Spinal Cord Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services SCT-Spinal Cord Therapeutics GmbH, a biopharmaceutical company based in Düsseldorf, Germany, is focused on the treatment of traumatic injury to the central nervous system. SCT`s proprietary key technology, the Regeneration Promoting Treatment, is an unique and promising treatment approach aimed at the supression of scar formation. The inhibition of scar formation allows the severed nerves to sprout and/or regenerate which in turn enables the recovery of sensory and motor function. As a first application of the Regeneration Promoting Treatment SCT is focusing on the development of Cordaneurin, a drug for the treatment of acute spinal cord injuries. In pre-clinical studies Cordaneurin has demonstrated its efficacy in the recovery of motor function after spinal cord contusion. | Presidente | 05/11/2009 | - |
CEVEC Pharmaceuticals GmbH
![]() CEVEC Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology CEVEC Pharmaceuticals GmbH engages in the manufacture of biopharmaceuticals using a human cell-based expression system. It provides therapeutic proteins and monoclonal antibodies. The company was founded by Stefan Kochanek in 2004 and is headquartered in Cologne, Germany. | Direttore operativo | - | - |
Direttore Finanziario/CFO | - | - | |
Presidente | 05/11/2009 | 25/07/2012 |
Statistiche
Distribuzione geografica
Germania | 7 |
Posizioni
Corporate Officer/Principal | 3 |
President | 2 |
Chief Operating Officer | 1 |
Settori
Health Technology | 6 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
MERCK KGAA | Health Technology |
Aziende private | 5 |
---|---|
CEVEC Pharmaceuticals GmbH
![]() CEVEC Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology CEVEC Pharmaceuticals GmbH engages in the manufacture of biopharmaceuticals using a human cell-based expression system. It provides therapeutic proteins and monoclonal antibodies. The company was founded by Stefan Kochanek in 2004 and is headquartered in Cologne, Germany. | Health Technology |
Merckle GmbH
![]() Merckle GmbH Pharmaceuticals: MajorHealth Technology Merckle GmbH engages in the manufacture of pharmaceutical products. It offers specialty and generic medicines, as well as over-the-counter drugs. The firm also provides management services for the group. The company was founded in 1881 and is headquartered in Blaubeuren, Germany. | Health Technology |
Ratiopharm GmbH
![]() Ratiopharm GmbH Pharmaceuticals: MajorHealth Technology ratiopharm GmbH engages in the production and distribution of generic drugs and pharmaceutical products. It offers pain relievers, nasal sprays, bronchial drops, as well as medicines for treating high blood pressure, cancer, pulmonary arterial hypertension, human immunodeficiency virus infection and acquired immune deficiency syndrome. The company was founded in 1973 and is headquartered in Ulm, Germany. | Health Technology |
SCT-Spinal Cord Therapeutics GmbH
![]() SCT-Spinal Cord Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services SCT-Spinal Cord Therapeutics GmbH, a biopharmaceutical company based in Düsseldorf, Germany, is focused on the treatment of traumatic injury to the central nervous system. SCT`s proprietary key technology, the Regeneration Promoting Treatment, is an unique and promising treatment approach aimed at the supression of scar formation. The inhibition of scar formation allows the severed nerves to sprout and/or regenerate which in turn enables the recovery of sensory and motor function. As a first application of the Regeneration Promoting Treatment SCT is focusing on the development of Cordaneurin, a drug for the treatment of acute spinal cord injuries. In pre-clinical studies Cordaneurin has demonstrated its efficacy in the recovery of motor function after spinal cord contusion. | Commercial Services |
Atriva Therapeutics GmbH
![]() Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Health Technology |
- Borsa valori
- Insiders
- Rainer Lichtenberger
- Esperienza